You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
POC Blood Coagulopathy Monitor
SBC: CFD RESEARCH CORPORATION Topic: DHA19A001Traumatic injuries account for 30% of all life years lost in the US and is the leading cause of death for people under 46 years of age. Uncontrolled bleeding or hemorrhage constitute 30-40% of trauma related deaths and are considered to be a major cause o
STTR Phase I 2019 Department of DefenseDefense Health Agency -
Smart Morphing Moulage Medical (SM3) Training Platform
SBC: LUNA INNOVATIONS INCORPORATED Topic: DHA17A002Medical moulage is used in medical training to simulate injuries or pathologies, however current moulage is static and does not provide the trainee feedback on the quality of care or ultimate outcome of that care. Allowing a trainee to witness the injury or pathology -morph- while treatment is being provided can provide feedback on any potential mistreatment and enhance the learning and proficienc ...
STTR Phase I 2017 Department of DefenseDefense Health Agency -
Oxygen Production and Delivery on Demand
SBC: GLOBAL RESEARCH & DEVELOPMENT INC Topic: DHA17B005This proposal is in response to the Defense Health Agency 2017 Phase I SBIR topic 17B-005.The approach is the use of a membrane oxygen pump using newly developed nano-thickness membranes with all the layers less than 1 micron total.Nanometer thickness membranes enable more oxygen output per surface area at temperatures of 300-600 C than current state-of-the -art 600-800 C membranes that are 50-300 ...
STTR Phase I 2018 Department of DefenseDefense Health Agency -
Enhanced WAAVES+: A Fast and Accurate Automated USV Scoring Program
SBC: CORNERSTONE RESEARCH GROUP INC Topic: DHP16C003Cornerstone Research Group (CRG) and the University of Texas (UT) will team to develop a fast and accurate automated analysis program for USV scoring. This automated tool will enable greater research efficiency and throughput allowing greater strides in developing treatments for post-traumatic stress disorder through rodent-based research. Building off prior work by UT on a first generation auto-s ...
STTR Phase I 2017 Department of DefenseDefense Health Agency -
Virus-Like Particle Based pan-Marburgvirus Vaccine
SBC: LUNA INNOVATIONS INCORPORATED Topic: CBD18A002Marburg virus (MARV) is a filamentous enveloped non-segmented negative sense RNA virus. This viruse is considered to be extremelydangerous with case fatality rates as high as 88-90%. Extensive efforts have gone towards effective vaccines for MARV prevention, however,none have been successfully established as licensed vaccines. Glycoprotein (GP) is the only surface protein of MARV. There are substa ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Electrotextile Systems for Human Signatures Monitoring
SBC: MANTEL TECHNOLOGIES, INC. Topic: DHA17A001Investments by the Department of Defense (DOD) have led to the development and demonstration of electronic textiles capable of transforming traditional textile systems into wearable power and data systems. The Defense Health Agency (DHA) has identified an opportunity to leverage advancements in smart garment systems for military personnel to aid in the prediction in performance declines and healt ...
STTR Phase I 2017 Department of DefenseDefense Health Agency -
Functionalized, Therapeutic-Loaded Liposomes for the Acute Treatment of TBI
SBC: LUNA INNOVATIONS INCORPORATED Topic: DHA18A001Traumatic brain injury is a common problem in both the military and civilian communities, but current treatment protocols are focused on managing symptoms and fail to prevent significant long-term repercussions. In the proposed program, Luna will demonstrate the feasibility of a liposome-based therapeutic delivery system capable of delivering hydrophilic and hydrophobic therapeutics to the traumat ...
STTR Phase I 2018 Department of DefenseDefense Health Agency -
Passive Pneumatic Prosthetic Ankle with Biomimetic Response
SBC: ADA TECHNOLOGIES, INC. Topic: DHP16C007The Defense Health Program seeks to improve the lives of service members suffering below knee amputations through the development of a non-powered lower extremity prosthesis designed to restore range of motion and power generation to that of an uninjured anatomical ankle. Current passive systems are still in early stages of development and typically only address one aspect of what the Defense Heal ...
STTR Phase I 2017 Department of DefenseDefense Health Agency -
Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases
SBC: CFD RESEARCH CORPORATION Topic: CBD18A001In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Developing Software for Pharmacodynamics and Bioassay Studies
SBC: TConneX Inc. Topic: DHP16C001Estimation of the primary parameters like IC 50 in traditional dose-response modelsmay fail or lead to misleading results when the observations are non-onotonic due to drugresistance or virus mutation in various biomedical lab research. The objective of this project isto develop a novel approach to assess dose response relationship, which is applicable to generalpharmacologic, toxicologic, or othe ...
STTR Phase I 2017 Department of DefenseDefense Health Agency